These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Prevention of thrombosis with coumarin, low doses of heparin, dextran and inhibitors of platelet function]. Loeliger EA Ned Tijdschr Geneeskd; 1977 Oct; 121(44):1748-54. PubMed ID: 335258 [No Abstract] [Full Text] [Related]
9. Heparin and low molecular weight heparin in thrombosis and beyond. Mousa SA Curr Opin Investig Drugs; 2002 Aug; 3(8):1181-6. PubMed ID: 12211411 [TBL] [Abstract][Full Text] [Related]
10. An evaluation of dextran in the prevention and treatment of thrombosis. Silver D Acta Chir Scand Suppl; 1968; 387():69-72. PubMed ID: 4240350 [No Abstract] [Full Text] [Related]
11. [Prophylaxis of thrombosis in surgical gynecology and obstetrics (author's transl)]. Voigt T; Voigt H Zentralbl Gynakol; 1980; 102(24):1401-9. PubMed ID: 6164182 [TBL] [Abstract][Full Text] [Related]
12. [Experimental-clinical evaluation of antithrombotic properties of polyglucin and rheopolyglucin in the treatment of acute venous thrombosis]. Savel'ev VS; Dumpe EP; Shestakov VA; Polushina TV; Il'in VN Probl Gematol Pereliv Krovi; 1974 Apr; 19(4):7-13. PubMed ID: 4832855 [No Abstract] [Full Text] [Related]
13. [The importance of thrombocytes for thrombogenesis and the pharmacological influencing of thrombocyte function (author's transl)]. Loew D MMW Munch Med Wochenschr; 1974 Aug; 116(31):1409-18. PubMed ID: 4212852 [No Abstract] [Full Text] [Related]
14. Inhibition of platelet thrombus formation by dextran. Evans RJ; Gordon JL J Pathol; 1973 Jan; 109(1):Pi-ii. PubMed ID: 4719744 [No Abstract] [Full Text] [Related]
15. [Prevention of postoperative thrombosis]. Vinazzer H Wien Med Wochenschr; 1977 Mar; 127(6):191-4. PubMed ID: 325911 [No Abstract] [Full Text] [Related]
16. Thrombotic and hemorrhagic problems in surgery. Rodvien R; Salzman EW Thromb Haemost; 1978 Apr; 39(2):254-62. PubMed ID: 580981 [No Abstract] [Full Text] [Related]
17. Comparison of warfarin, low-molecular-weight dextran, aspirin, and subcutaneous heparin in prevention of venous thromboembolism following total hip replacement. Harris WH; Salzman EW; Athanasoulis C; Waltman AC; Baum S; DeSanctis RW J Bone Joint Surg Am; 1974 Dec; 56(8):1552-62. PubMed ID: 4434023 [No Abstract] [Full Text] [Related]
18. [Antithrombotic agents for the prevention of thromboses during infraclavicular vena cava catheterizaiton]. Fassolt A; Brändli F; Braun U Infusionsther Klin Ernahr; 1979; 6(1):50-4. PubMed ID: 570551 [TBL] [Abstract][Full Text] [Related]
19. Comparison of arterial and venous patency in a rat model of subendothelium-stimulated thrombosis. Hupkens P; Cooley BC Microsurgery; 1996; 17(4):226-9. PubMed ID: 9140956 [TBL] [Abstract][Full Text] [Related]
20. A study of the in vitro and in vivo effects of a synthetic heparin-like anticoagulant: dextran sulphate. HJORT P; STORMORKEN H; GILJE O Scand J Clin Lab Invest; 1957; 9 Suppl 29():1-86. PubMed ID: 13506569 [No Abstract] [Full Text] [Related] [Next] [New Search]